Date published: 2026-5-19

1-800-457-3801

SCBT Portrait Logo
Seach Input

TREK-1 Activators

TREK-1 activators constitute a class of chemicals that act to enhance the function of the TREK-1 potassium channel, a member of the two-pore domain potassium (K2P) channel family. These channels are involved in maintaining the resting membrane potential and cellular excitability in neurons. TREK-1 activators achieve their effects either by directly interacting with the channel and increasing its open probability or by modulating the channel's gating mechanisms. This group of chemicals comprises a diverse set of compounds, including certain fatty acids, endocannabinoids, a neuroprotective agent, a small molecule activator, a nonsteroidal anti-inflammatory drug and a phosphodiesterase 5 inhibitor. Arachidonic acid, oleic acid, and linolenic acid are polyunsaturated fatty acids that directly activate TREK-1 channels. The binding of these fatty acids to TREK-1 increases the channel's open probability, leading to greater potassium conductance and hyperpolarisation of the neuronal membrane. Similarly, endocannabinoids such as anandamide, N-arachidonoyl dopamine, N-arachidonoyl serotonin, and 2-Arachidonoylglycerol interact directly with the TREK-1 channel, enhancing its open probability and thus leading to increased potassium conductance and hyperpolarisation.

Riluzole, a neuroprotective agent, and ML67-33, a small molecule activator, also directly activate the TREK-1 channel, enhancing its conductance and contributing to neuronal membrane hyperpolarisation. BL-1249, a nonsteroidal anti-inflammatory drug (NSAID), and vardenafil, a phosphodiesterase 5 inhibitor, activate TREK-1 channels via distinct mechanisms, but both lead to an increased open probability of the channel and thus increased potassium conductance and neuronal membrane hyperpolarisation. Lastly, palmitoyl ethanolamide, a fatty acid amide, acts directly on TREK-1 to enhance its open probability, leading to increased potassium conductance and hyperpolarisation of the neuronal membrane. In summary, all these chemical activators of TREK-1 work by enhancing the open probability of the channel, thus increasing potassium conductance and leading to neuronal membrane hyperpolarisation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Arachidonic Acid (20:4, n-6)

506-32-1sc-200770
sc-200770A
sc-200770B
100 mg
1 g
25 g
$92.00
$240.00
$4328.00
9
(1)

Arachidonic acid, a polyunsaturated fatty acid, activates TREK-1 channels via direct binding. The binding of arachidonic acid increases the open probability of TREK-1 channels, leading to an increase in potassium conductance and hyperpolarisation of the neuronal membrane.

Oleic Acid

112-80-1sc-200797C
sc-200797
sc-200797A
sc-200797B
1 g
10 g
100 g
250 g
$37.00
$104.00
$580.00
$1196.00
10
(1)

Oleic acid, a monounsaturated fatty acid, directly activates TREK-1 channels. Like arachidonic acid, oleic acid binding increases the open probability of TREK-1 channels, enhancing potassium conductance and leading to neuronal membrane hyperpolarisation.

α-Linolenic Acid

463-40-1sc-205545
sc-205545A
50 mg
250 mg
$38.00
$115.00
2
(2)

Linolenic acid, a polyunsaturated fatty acid, activates TREK-1 channels in a manner similar to arachidonic acid and oleic acid. Its binding increases the channel open probability, enhancing potassium conductance and promoting neuronal membrane hyperpolarisation.

Riluzole

1744-22-5sc-201081
sc-201081A
sc-201081B
sc-201081C
20 mg
100 mg
1 g
25 g
$20.00
$193.00
$213.00
$317.00
1
(1)

Riluzole, a neuroprotective agent, directly activates TREK-1 channels. The activation of TREK-1 by riluzole enhances potassium conductance and hyperpolarises the neuronal membrane, contributing to its neuroprotective properties.

Palmitoylethanolamide

544-31-0sc-202754
sc-202754A
sc-202754B
sc-202754C
sc-202754D
10 mg
50 mg
500 mg
1 g
10 g
$80.00
$243.00
$2091.00
$3339.00
$16657.00
(1)

Palmitoyl ethanolamide, a fatty acid amide, activates TREK-1 channels. Its direct interaction with the channel enhances its open probability, leading to increased potassium conductance and membrane hyperpolarisation.

Vardenafil

224785-90-4sc-362054
sc-362054A
sc-362054B
100 mg
1 g
50 g
$526.00
$735.00
$16653.00
7
(1)

Vardenafil, a phosphodiesterase 5 inhibitor, enhances the activity of TREK-1 channels. Its action increases the open probability of TREK-1 channels, leading to increased potassium conductance and neuronal membrane hyperpolarisation.